Cargando…

Anti-inflammatory substances from onions could be an option for treatment of COVID-19—a hypothesis

Detalles Bibliográficos
Autores principales:	Dorsch, W., Ring, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Medizin 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573243/ https://www.ncbi.nlm.nih.gov/pubmed/33101838 http://dx.doi.org/10.1007/s40629-020-00146-2

Ejemplares similares

Anti-inflammatory substances from onions could be an option for treatment of COVID-19 - a hypothesis
por: Dorsch, Walter, et al.
Publicado: (2020)

Substance P, proinflammatory cytokines, transient receptor potential vanilloid subtype 1 and COVID-19: a working hypothesis()
por: Aguirre-Siancas, E.E., et al.
Publicado: (2021)

Onion-cadmium-renal function: Relationship?
por: Wiwanitkit, V.
Publicado: (2010)

Stem cells as an option for the treatment of COVID-19
por: Cuevas-González, Maria Veronica, et al.
Publicado: (2022)

Letter regarding “A novel bone marrow‐sparing treatment for primary erythrocytosis in a cat: Onion powder”: Food for thought instead of onion powder as a treatment for erythrocytosis in cats
por: Giger, Urs, et al.
Publicado: (2021)

Serine protease inhibitors could be of benefit in the treatment of COVID-19 disease
por: Okeahialam, Basil N.
Publicado: (2021)

Hemodynamic Monitoring Options in COVID-19
por: Rozental, Olga, et al.
Publicado: (2020)

Eating garlic and onion: a matter of life or death
por: Izzo, A A, et al.
Publicado: (2004)

A family intoxicated by daffodil bulbs mistaken for onions
por: Ageta, Kohei, et al.
Publicado: (2020)

Is teicoplanin a complementary treatment option for COVID-19? The question remains
por: Ceccarelli, Giancarlo, et al.
Publicado: (2020)

Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?
por: Takagi, Hisato
Publicado: (2020)

Could the COVID-19 pandemic aggravate antimicrobial resistance?
por: Rossato, Luana, et al.
Publicado: (2020)

Immunotherapies for COVID-19: Restoring the immunity could be the priority
por: Allaouchiche, Bernard
Publicado: (2020)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Prevention, treatment and care of substance use disorders in times of COVID‐19
por: Volkow, Nora D., et al.
Publicado: (2022)

Is there a place for anti-inflammatory therapy in COVID-19?
por: Yew, Wing Wai, et al.
Publicado: (2020)

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment
por: Rajput, Dinesh Vijay
Publicado: (2020)

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis
por: Meenakshisundaram, Ramachandran, et al.
Publicado: (2020)

Hyperactivated Mast Cells Pathogenesis Hypothesis for COVID-19 Cutaneous Manifestations
por: Ricke, Darrell O.
Publicado: (2021)

Periodontal pocket and COVID-19: Could there be a possible link?
por: Elisetti, Nirupa
Publicado: (2021)

siRNA could be a potential therapy for COVID-19
por: Ghosh, Sanhita, et al.
Publicado: (2020)

COVID-19 patients could be at high risk for dry socket
por: Shetty, Lakshmi, et al.
Publicado: (2021)

Could Curcumin Modified Silver Nanoparticles Treat COVID-19?
por: Law, Siukan, et al.
Publicado: (2022)

Renal failure in COVID-19 ARDS: Could it be partially avoided?
por: Zakynthinos, George E., et al.
Publicado: (2021)

Could diet and exercise reduce risk of COVID-19 syndemic?
por: Chesnut, Walter M., et al.
Publicado: (2021)

Could immune activation cause pancreatitis in COVID-19 patients?
por: Alberca, Gabriela Gama Freire, et al.
Publicado: (2022)

The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment
por: Ornell, Felipe, et al.
Publicado: (2020)

Finding the right time for anti-inflammatory therapy in COVID-19
por: de Simone, Giovanni, et al.
Publicado: (2020)

The Potential Anti-Inflammatory Effects of Zerumbone in COVID-19 Patients
por: Dehghan, Razieh, et al.
Publicado: (2021)

Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis
por: González-Duarte, Alejandra, et al.
Publicado: (2020)

Hypoxia inducible factor-1 protects against COVID-19: A hypothesis
por: Afsar, Baris, et al.
Publicado: (2020)

Reduction in the incidence of infectious diseases during the COVID-19 pandemic: A hypothesis
por: MohammadSadeghi, Ashkan
Publicado: (2021)

Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!
por: Magoon, Rohan, et al.
Publicado: (2021)

Pericardial Cytokine “Storm” in a COVID-19 Patient: the Confirmation of a Hypothesis
por: Deana, Cristian, et al.
Publicado: (2021)

Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis
por: Swarnakar, Raktim, et al.
Publicado: (2022)

COVID-19 therapeutic options for patients with kidney disease
por: Izzedine, Hassan, et al.
Publicado: (2020)

Diagnostic options for coronavirus disease 2019 (COVID-19)
por: Xiao, Yuanyuan, et al.
Publicado: (2020)

Response to letter regarding “A novel bone marrow‐sparing treatment for primary erythrocytosis in a cat: Onion powder”
por: Gilor, Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h5c9c05g1tb39ao20bndqnru3s